Common use of Testing for Controlled Substances Clause in Contracts

Testing for Controlled Substances. All employees of the District in safety-sensitive positions shall be subject to testing for use of controlled substances (drugs). Drug testing will be accomplished by analysis of a sample of the employee’s urine conducted at a Department of Health and Human Services (DHHS) certified laboratory. All urine specimens will be analyzed only for the following drugs, using Enzyme Multiplied Immunoassay Technique (EMIT) screen test as a following nanograms/milliliter screening levels: 1. Marijuana (THC metabolite) 50 ng/ml 2. Cocaine 300 ng/ml 3. Amphetamines 1000 ng/ml 4. Opiates (including heroin) 300 ng/ml 5. Phencyclidine (PCP 25 ng/ml Each employee’s urine sample will be subdivided into two (2) bottles labeled as “primary” and “split” specimens. Only the primary specimen will be opened and used for urinalysis. The split specimen bottle will remain sealed and will be stored at the laboratory. If the analysis of the primary specimen shows the presence of an illegal controlled substance, the employee shall be notified by the Medical Review Officer (MRO), and will have seventy-two (72) hours to request that the split specimen be sent to another DHHS certified laboratory for analysis. If the drug screening test(s) indicate(s) the presence of one (1) or more of listed drugs, then a confirmation test will be performed for each identified drug using state- of-the-art gas chromatography/mass spectrometry (GC/MS) analysis, at the following nanograms/milliliter screening levels: 1. Marijuana (THC metabolite) 15 ng/ml 2. Cocaine 150 ng/ml 3. Amphetamines/Methamphetamine 500 ng/ml 4. Opiates (including heroin) 300 ng/ml 5. Phencyclidine (PCP) 25 ng/ml

Testing for Controlled Substances. All employees of the District in safety-sensitive positions Agency shall be subject to testing for use of controlled substances (or drugs). Drug testing will be accomplished by analysis of a sample of the employee’s urine conducted at a professional testing laboratory certified and monitored by the Department of Health and Human Services (DHHS) certified laboratory). All urine specimens will be analyzed only for the following drugs, using Enzyme Multiplied Immunoassay Technique (EMIT) screen test as a following nanograms/milliliter screening levels: (1. ) Marijuana (THC metabolite) (2) 50 ng/ml 2. Cocaine 300 ng/ml Cocaine (3. Amphetamines 1000 ng/ml ) Amphetamines (4. ) Opiates (including heroin, codeine and morphine) (5) 300 ng/ml 5. Phencyclidine (PCP 25 ng/ml PCP) Each employee’s urine sample will be subdivided into two (2) bottles labeled as “primary” and “split” specimens. Only the primary specimen will be opened and used for urinalysis. The split specimen bottle will remain sealed and will be stored at the laboratory. If the drug screening test(s) indicate the presence of one or more of these drugs, then a confirmation test will be performed for each identified drug using state-of-the-art chromatography mass spectrometry (GC/MS) analysis. If the analysis of the primary specimen shows the presence of an illegal controlled substance, the employee shall be notified by of the Medical Review Officer (MRO), and the MRO will notify the individual they will have seventy-two (72) 72 hours to request that the split specimen be sent to another DHHS certified laboratory for analysis. If the drug screening test(s) indicate(s) the presence of one analysis (1) or more of listed drugs, then a confirmation test such will be performed for each identified drug using state- of-the-art gas chromatography/mass spectrometry (GC/MS) analysis, done at the following nanograms/milliliter screening levels: 1. Marijuana (THC metabolite) 15 ng/ml 2. Cocaine 150 ng/ml 3. Amphetamines/Methamphetamine 500 ng/ml 4. Opiates (including heroin) 300 ng/ml 5. Phencyclidine (PCP) 25 ng/mlemployee’s own expense if the confirming test is positive, but the Agency would pay in full if the confirming test is negative.)

Testing for Controlled Substances. All employees of the District in safety-sensitive positions shall be subject to testing for use of controlled substances (drugs). Drug testing will be accomplished by analysis of a sample of the employee’s urine conducted at a Department of Health and Human Services (DHHS) certified laboratory. All urine specimens will be analyzed only for the following drugs, using Enzyme Multiplied Immunoassay Technique (EMIT) screen test as a following nanograms/milliliter screening levels: 1. Marijuana (THC metabolite) 50 ng/ml 2. Cocaine 300 ng/ml 3. Amphetamines 1000 ng/ml 4. Opiates (including heroin) 300 ng/ml 5. Phencyclidine (PCP 25 ng/ml Each employee’s urine sample will be subdivided into two (2) bottles labeled as “primary” and “split” specimens. Only the primary specimen will be opened and used for urinalysis. The split specimen bottle will remain sealed and will be stored at the laboratory. If the analysis of the primary specimen shows the presence of an illegal controlled substance, the employee shall be notified by the Medical Review Officer (MRO), and will have seventy-two (72) hours to request that the split specimen be sent to another DHHS certified laboratory for analysis. If the drug screening test(s) indicate(s) the presence of one (1) or more of listed drugs, then a confirmation test will be performed for each identified drug using state- state-of-the-art gas chromatography/mass spectrometry (GC/MS) analysis, at the following nanograms/milliliter screening levels: 1. Marijuana (THC metabolite) 15 ng/ml 2. Cocaine 150 ng/ml 3. Amphetamines/Methamphetamine 500 ng/ml 4. Opiates (including heroin) 300 ng/ml 5. Phencyclidine (PCP) 25 ng/ml

Testing for Controlled Substances. All employees of the District in safety-sensitive positions shall be subject to testing for use of controlled substances (drugs). Drug testing will be accomplished by analysis of a sample of the employee’s urine conducted at a Department of Health and Human Services (DHHS) certified laboratory. All urine specimens will be analyzed only for the following drugs, using Enzyme Multiplied Immunoassay Technique (EMIT) screen test as a following nanograms/milliliter screening levels: 1. Marijuana (THC metabolite) 50 ng/ml 2. Cocaine 300 ng/ml 3. Amphetamines 1000 ng/ml 4. Opiates (including heroin) 300 ng/ml 5. Phencyclidine (PCP PCP) 25 ng/ml Each employee’s urine sample will be subdivided into two (2) bottles labeled as “primary” and “split” specimens. Only the primary specimen will be opened and used for urinalysis. The split specimen bottle will remain sealed and will be stored at the laboratory. If the analysis of the primary specimen shows the presence of an illegal controlled substance, the employee shall be notified by the Medical Review Officer (MRO), and will have seventy-two (72) hours to request that the split specimen be sent to another DHHS certified laboratory for analysis. If the drug screening test(s) indicate(s) the presence of one (1) or more of listed drugs, then a confirmation test will be performed for each identified drug using state- of-the-art gas chromatography/mass spectrometry (GC/MS) analysis, at the following nanograms/milliliter screening levels: 1. Marijuana (THC metabolite) 15 ng/ml 2. Cocaine 150 ng/ml 3. Amphetamines/Methamphetamine 500 ng/ml 4. Opiates (including heroin) 300 ng/ml 5. Phencyclidine (PCP) 25 ng/ml